OC-0635 Targeting TEMPRSS2:ERG fusion to achieve a tumor-specific radiosensitization in prostate cancer. (April 2019) - Köcher, S.; Beyer, B.; Lange, T.; Nordquist, L.; Burdak-Rothkamm, S.; Schlomm, T.; Petersen, C.; Rothkamm, K.; Mansour, W.